Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 1831 results found. Search for [ Indian pharma ]

Results 20 to 40 of 1831
PTI
May 22, 2019



PTI
May 21, 2019



PTI
May 21, 2019



PTI
May 21, 2019



BusinessToday.In
May 21, 2019
Share Market Update: Market Breadth was in favour of sellers, as 1134 stocks declined on NSE against 509 advancing stocks, while 75 remained unchanged. Similarly, 1608 stocks were declining on BS against 936 adavcing stocks, while 143 remained unchanged.


BusinessToday.In
May 20, 2019
The biggest move was seen on Nifty PSU banks that closed at 7.88 per cent gain, followed by realty that closed with a gain of 5.72 per cent


PTI
May 20, 2019



BusinessToday.In
New Delhi, May 20, 2019
BSE Sensex is up 1445.67 points or 3.81 per cent at 39,376.44 and NSE Nifty is trading up by 420.70 or 3.69 per cent at 11,827.85, in the last hour of trade.


Reuters
New Delhi, May 19, 2019
Two sources familiar with J&J's operations in India and one state government official told production at the plant, at Penjerla in Telangana, never began because of a slowing in the growth in demand for the products


BusinessToday.In
May 18, 2019
Experts said markets overcame global jitters due to US-China trade war and turned their focus on the Lok Sabha election 2019.


PTI
May 17, 2019
Bajaj Finance was the top gainer in the Sensex pack.


PTI
May 17, 2019
Revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same quarter last fiscal, the city-based drug-maker said in a press release.


PTI
New Delhi, May 17, 2019
During the week, the Sensex gained 467.78 points and the Nifty advanced 128.25 points; global markets were mixed following sharper rhetoric from China on the trade dispute with the US


PTI
May 17, 2019



PB Jayakumar
May 17, 2019
Despite the pressure of business in the US, pharma major Lupin Limited recorded a 5.2 per cent rise in revenues to Rs 16,369.4 crore in FY19


PTI
May 16, 2019



E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


PTI
May 15, 2019



PB Jayakumar
New Delhi, May 15, 2019
In 2018, India has the largest number of US regulator approved pharmaceutical plants outside the US.


BusinessToday.In
New Delhi, May 15, 2019
India postpones retaliatory tariff deadline on US products to Jun 16, RBI needs to go for larger rate cut in next monetary policy review, Indian firm Glenmark may face a penalty of up to $873 million and other news on News Blast.


PAGES 2 OF 92  12345